Effective at the opening of trading on the Effective Date, the Company’s pre-consolidated common shares will be delisted from the Exchange and the post-consolidated common shares will commence trading ...

The "A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products Training Course" has been added to ResearchAndMarkets.com's offering. Understanding the chemistry, ...

CFO Joe Vazzano disclosed that Abeona had $98.1 million in cash and equivalents as of December 31, 2024, providing financial resources to fund operations into 2026 without considering potential pz-cel ...

Ladenburg, Germany, 21 March 2025 – Heidelberg Pharma AG (FSE: HPHA) today published its financial results and Annual Report for fiscal year 2024 (1 December 2023 – 30 November 2024) and its outlook ...

Wheeler Bio, an innovative contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing of antibody-based therapies, announced the closing of ...

Cellogen Therapeutics’ CAR T cell technology introduces a bi-specific approach to cancer immunotherapy. Unlike conventional ...

This therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and ...

Bi-Specific 3rd Generation CAR T therapy is a revolutionary advancement in cellular immunotherapy, primarily used to treat blood cancers such as leukemia, lymphoma, and multiple myeloma.

Digital bank Revolut is focused on its ongoing transformation into a fully-fledged bank with several key strategic ...

Bitcoin’s price plummets—should you “buy the dip”? Plus, Canada’s first levered bitcoin and ethereum ETFs are here.